Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-5594
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma ; day:7 ; month:6 ; year:2018 ; pages:1-15
Oncogene ; (7.6.2018), 1-15

Classification
Medizin, Gesundheit

Creator
Boboila, Shuobo
Contributor
Lopez, Gonzalo
Yu, Jiyang
Banerjee, Debarshi
Kadenhe-Chiweshe, Angela
Connolly, Eileen P.
Kandel, Jessica J.
Rajbhandari, Presha
Silva, Jose M.
Califano, Andrea
Yamashiro, Darrell J.
SpringerLink (Online service)

DOI
10.1038/s41388-018-0326-9
URN
urn:nbn:de:101:1-2018081216384579211768
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Boboila, Shuobo
  • Lopez, Gonzalo
  • Yu, Jiyang
  • Banerjee, Debarshi
  • Kadenhe-Chiweshe, Angela
  • Connolly, Eileen P.
  • Kandel, Jessica J.
  • Rajbhandari, Presha
  • Silva, Jose M.
  • Califano, Andrea
  • Yamashiro, Darrell J.
  • SpringerLink (Online service)

Other Objects (12)

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma

Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma

Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma

LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma

Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma

The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells

The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells

Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma

Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma

Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells

Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma

Related objects